Bempedoic acid effective for statin-intolerant patients
In The News: Bempedoic acid is an FDA-approved drug for the treatment of hypercholesterolemia sold under the brand name Nexletol. It is an ATP citrate lyase
In The News: Bempedoic acid is an FDA-approved drug for the treatment of hypercholesterolemia sold under the brand name Nexletol. It is an ATP citrate lyase
Focus on Drug Discovery: Saridegib is a natural product-inspired drug candidate. Its prototype, cyclopamine was discovered as a teratogenic steroidal alkaloid that was found to cause
Journal Club: Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder caused by the expression of progerin, a Lamin A mutant. The study of HGPS
Journal Club: In a paper just out in PNAS, Y. Lin and coworkers showed that Eltrombopag, an FDA-approved drug for thrombocytopenia, inhibits autophagy by targeting the
Journal Club: A paper just out in J. Proteomics by Herman Sintim and coworkers at Purdue sheds new light on the signaling roles of the cyclic
In The News: Bempedoic acid is an FDA-approved drug for the treatment of hypercholesterolemia sold under the brand name Nexletol. It is an ATP citrate lyase
Website Created by Advanta Advertising LLC.